학술논문
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model.
Document Type
Article
Author
Yun Hu; Paris, Sébastien; Bertolet, Genevieve; Barsoumian, Hampartsoum B.; Qi Wang; Da Silva, Jordan; Patel, Nalini B.; Nguyen Nguyen; Doss, Denaha J.; Ailing Huang; Ethan Hsu; Leyton, Claudia S. Kettlun; Voss, Tiffany A.; Masrorpour, Fatemeh; Leuschner, Carola; Pietz, Jordan T.; Puebla-Osorio, Nahum; Gandhi, Saumil; Quynh-Nhu Nguyen; Jing Wang
Source
Frontiers in Immunology; 11/3/2022, Vol. 13, p1-16, 16p
Subject
Language
ISSN
16643224
Abstract
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)